Search - tctmd.com

Displaying 381 - 400 of 537

Sort: Relevancy | Date

News Daily News

Substudy Suggests Invasive Strategy Better for Elderly NSTE-ACS Patients

January 28, 2015

News Daily News

For CKD Patients, CABG Favored Long-term Over PCI

Yael L. Maxwell

January 28, 2015

Presentation

Effect of an Invasive Strategy on Outcome in Patients ≥ 75 Years of Age With NSTE-ACS

Presenter: Gennaro Galasso

January 11, 2015

News Daily News

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

Todd Neale

December 22, 2014

News Daily News

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

Yael L. Maxwell

December 15, 2014

News Daily News

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

December 04, 2014

News Daily News

Most Operators Still Eyeball Intermediate Lesions Despite Recommendations for FFR

November 17, 2014

News Conference News AHA 2014

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

November 16, 2014

News Daily News

OCT Analysis Reveals Pattern of Delayed DES Coverage in CTOs

October 17, 2014

News Daily News

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

Caitlin E. Cox

October 03, 2014

News Daily News

2014 Guideline for NSTE-ACS Management Has New Name, Focus

September 30, 2014

News Conference News TCT 2014

SMILE: One-Stage PCI Superior for Non-STEMI and Multivessel CAD

September 14, 2014

News Conference News TCT 2014

PCI for CTO Ups Survival vs. Medical Therapy, CABG

September 14, 2014

News Daily News

STREAM: La Estrategia Inicial Fibrinolítica es Segura al cabo de 1 Año cuando la realización de una PCI Primaria en el Momento Adecuado es Inalcanzable

L.A. McKeown

September 11, 2014

News Daily News

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

L.A. McKeown

September 11, 2014

News Daily News

STREAM：在无法及时采取直接PCI时，尽快采取纤维蛋白溶解策略在1年时是安全的

L.A. McKeown

September 11, 2014

News Daily News

Initial Thrombolysis Found to Be the Most Costly Strategy for Acute Limb Ischemia

September 08, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

News Conference News ESC 2014

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

Caitlin E. Cox

September 03, 2014

Presentation ESC 2014

10-year mortality outcome of a routine invasive strategy in non-ST segment elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial

Presenter: Robert A. Henderson

September 02, 2014

Advertisement

Substudy Suggests Invasive Strategy Better for Elderly NSTE-ACS Patients

For CKD Patients, CABG Favored Long-term Over PCI

Effect of an Invasive Strategy on Outcome in Patients ≥ 75 Years of Age With NSTE-ACS

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

Most Operators Still Eyeball Intermediate Lesions Despite Recommendations for FFR

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

OCT Analysis Reveals Pattern of Delayed DES Coverage in CTOs

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

2014 Guideline for NSTE-ACS Management Has New Name, Focus

SMILE: One-Stage PCI Superior for Non-STEMI and Multivessel CAD

PCI for CTO Ups Survival vs. Medical Therapy, CABG

STREAM: La Estrategia Inicial Fibrinolítica es Segura al cabo de 1 Año cuando la realización de una PCI Primaria en el Momento Adecuado es Inalcanzable

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

STREAM：在无法及时采取直接PCI时，尽快采取纤维蛋白溶解策略在1年时是安全的

Initial Thrombolysis Found to Be the Most Costly Strategy for Acute Limb Ischemia

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

10-year mortality outcome of a routine invasive strategy in non-ST segment elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content